Geisinger Medical Laboratories Test Catalog

Order Display Name: Geisinger Epic Procedure Code Or ID CPT Code:  

EBV VIRAL CAPSID ANTIGEN IGG ANTIBODY

ORDERING INFORMATION:
Geisinger Epic Procedure Code: LAB2230         Geisinger Epic ID: 14931

SPECIMEN COLLECTION
Specimen type:
 Serum
Preferred collection container:
Alternate Collection Container:
6 mL red-top (plain, non-serum separator) tube
Specimen required:
0.5 mL serum; minimum 0.2 mL
SPECIMEN PROCESSING
Specimen processing instructions:
Allow to clot. Centrifuge and submit 0.5 mL serum. 
Transport temperature:
 Refrigerated (preferred). Room temperature (stable 8 hours) and frozen specimens also acceptable.
Specimen stability:
 Room temperature: 8 hours. 2-8°C: 96 hours. Frozen: 6 months
Rejection criteria:
 Specimen stability exceeded; specimen grossly hemolyzed.
TEST DETAILS
Interpretation guide:
Result
Interpretation
Negative Absence of detectable VCA IgG antibodies. If exposure to Epstein-Barr virus is suspected despite a negative finding, a second sample should be collected and tested no less than one to two weeks later.
Equivocal Suggest a second sample be collected and tested one to two weeks later.
Positive Presence of detectable VCA IgG antibodies. A positive result indicates current or past exposure to Epstein-Barr virus.

This test is for the qualitative determination of IgG antibodies to EBV VCA.
CPT code(s):
 86665
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.  The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.
Test includes:
 Antibody detection to EBVCA IgG.
Methodology:
Chemiluminescence
Synonyms:
EB-VCA IgG, EBV IGG AB
Epstein Barr IgG Antibody
Epstein Barr IgG antibodies to viral capsid
Clinical significance:
Epstein-Barr virus (EBV) is responsible for infectious mononucleosis (IM) and has also been implicated in Burkitt's lymphoma and nasopharyngeal carcinoma. EBV-VCA IgG antibodies appear at clinical onset of IM and generally peak after 10 weeks. IgG antibodies to EBV-VCA persist through life and by themselves are not indicative of a current infection.
Doctoral Director(s:)
Hoi-Ying Elsie Yu PhD, DABCC    
Review Date: 12/13/2022

Performing Locations

Geisinger Medical Center

Performing laboratory: Immunology
Technical Lead: Kathy Hurst
Frequency: Five days per week, 1st shift.
Performed STAT? No
Locations  |    Search  |    Site Map |   Contact Us
©2000-2023 Geisinger Health System.   All rights reserved.